The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Stephen I. Pelton

Boston University School of Medicine and Maxwell Finland Laboratory for Infectious Diseases

Boston Medical Center

MA 02118



Name/email consistency: high



  • Boston University School of Medicine and Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA. 1999 - 2010
  • Department of Pediatrics, Boston Medical Center, USA. 1999 - 2009
  • Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine, Boston, USA. 2007
  • Section of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, 774 Albany Street-Suite 512, USA. 2000 - 2005
  • Boston Medical Center, Boston, MA 02118, USA. 2005
  • Departments of Pediatrics and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA 02118, USA. 2005


  1. 7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: effectiveness of a 2-dose versus 3-dose primary series. Pelton, S.I., Weycker, D., Klein, J.O., Strutton, D., Ciuryla, V., Oster, G. Vaccine (2010) [Pubmed]
  2. Expanding prevention of invasive meningococcal disease. Pelton, S.I., Gilmet, G.P. Expert. Rev. Vaccines (2009) [Pubmed]
  3. Recent advances in otitis media. Pelton, S.I., Leibovitz, E. Pediatr. Infect. Dis. J. (2009) [Pubmed]
  4. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pelton, S.I., Huot, H., Finkelstein, J.A., Bishop, C.J., Hsu, K.K., Kellenberg, J., Huang, S.S., Goldstein, R., Hanage, W.P. Pediatr. Infect. Dis. J. (2007) [Pubmed]
  5. Prospects for prevention of otitis media. Pelton, S.I. Pediatr. Infect. Dis. J. (2007) [Pubmed]
  6. Improving the outcome of pneumococcal meningitis. Pelton, S.I., Yogev, R. Arch. Dis. Child. (2005) [Pubmed]
  7. Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children. Pelton, S.I., Stanley, K., Yogev, R., Fletcher, C.V., McIntosh, K., Wiznia, A., Nachman, S. Clin. Infect. Dis. (2005) [Pubmed]
  8. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pelton, S.I. Pediatr. Clin. North Am. (2005) [Pubmed]
  9. The decline in invasive pneumococcal disease. Pelton, S.I. Pediatrics (2004) [Pubmed]
  10. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pelton, S.I. Pediatr. Infect. Dis. J. (2002) [Pubmed]
  11. Efficacy of linezolid in experimental otitis media. Pelton, S.I., Figueira, M., Albut, R., Stalker, D. Antimicrob. Agents Chemother. (2000) [Pubmed]
  12. Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?. Pelton, S.I. Vaccine (2000) [Pubmed]
  13. A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir. Pelton, S.I., Johnson, D., Chadwick, E., Baldwin, Z., Yogev, R. Pediatr. Infect. Dis. J. (1999) [Pubmed]
  14. The promise of immunoprophylaxis for prevention of acute otitis media. Pelton, S.I., Klein, J.O. Pediatr. Infect. Dis. J. (1999) [Pubmed]
WikiGenes - Universities